Total saponin from Korean red ginseng inhibits thromboxane A2 production associated microsomal enzyme activity in platelets

Journal of Ginseng Research

Volumn 36, Issue 1, 2012, Pages 40-46

  Lee, Dong Hwa ^a   Cho, Hyun Jeong ^b   Kang, Hye Yeon ^b   Rhee, Man Hee ^c   Park, Hwa Jin ^a  

^a Inje University   (South Korea)

^b Konyang University   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

Cyclooxygenase 1; Total saponin from korean red ginseng

Indexed keywords

PANAX GINSENG;

EID: 84862944450     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.5142/jgr.2012.36.1.40     Document Type: Article

References (38)

1. Schwartz SM, Heimark RL, Majesky MW. Developmental mechanisms underlying pathology of arteries. Physiol Rev 1990;70:1177-1209.
2. Berridge MJ, Irvine RF. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 1984;12:15-21.
3. Jennings LK. Role of platelets in atherothrombosis. Am J Cardiol 2009;10(Suppl):4A-10A.
4. Pasqui AL, Capecchi PL, Ceccatelli L, Mazza S, Gistri A, Laghi Pasini F, Di Perri T. Nitroprusside in vitro inhibits platelet aggregation and intracellular calcium translocation. Effect of haemoglobin. Thromb Res 1991;61:11-122.
5. Nishikawa M, Tanaka T, Hidaka H. Ca2+-calmodulindependent phosphorylation and platelet secretion. Nature 1980;287:86-865.
6. Murakami K, Chan SY, Routtenberg A. Protein kinase C activation by cis-fatty acid in the absence of Ca2+ and phospholipids. J Biol Chem 1986;261:15424-15429.
7. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A 1975;72:2994-2998.
8. Cattaneo M, Tenconi PM, Lecchi A, Mannucci PM. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. Thromb Res 1991;62:717-724.
9. Moriyama T, Takamura H, Narita H, Tanaka K, Matsuura T, Kito M. Elevation of cytosolic free Ca2+ is directly evoked by thromboxane A2 in human platelets during activation with collagen. J Biochem 1988;10:901-902.
10. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994;0:1287-1294.
11. Cipollone F, Patrignani P, Greco A, Panara MR, Padovano R, Cuccurullo F, Patrono C, Rebuzzi AG, Liuzzo G, Quaranta G et al. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation 1997;96:1109-1116.
12. Patrono C. Aspirin: new cardiovascular uses for an old drug. Am J Med 2001;110:62S-65S.
13. Ichikawa K, Tazawa S, Hamano S, Kojima M, Hiraku S. Effect of ozagrel on locomotor and motor coordination after transient cerebral ischemia in experimental animal models. Pharmacology 1999;59:257-265.
14. Park HJ, Lee JH, Song YB, Park KH. Effects of dietary supplementation of lipophilic fraction from Panax ginseng on cGMP and cAMP in rat platelets and on blood coagulation. Biol Pharm Bull 1996;19:144-149.
15. Park HJ, Rhee MH, Park KM, Nam KY, Park KH. Effect of non-saponin fraction from Panax ginseng on cGMP and thromboxane A2 in human platelet aggregation. J Ethnopharmacol 1995;49:157-162.
16. Rhee MH, Park KM, Park HJ, Nam KY, Park KH. Inhibition of serotonin release by lipophilic fraction from Korean red ginseng. Korean J Ginseng Sci 199;17:127-10.
17. Park HJ, No YH, Rhee MH, Park KM, Park KH. Effects of protein fractions and ginsenosides from Panax ginseng C.A. Meyer on substrate phosphorylation by a catalytic fragment of protein kinase. Korean Biochem J 1994;27:280-28.
18. Kuo SC, Teng CM, Lee JC, Ko FN, Chen SC, Wu TS. Antiplatelet components in Panax ginseng. Planta Med 1990;56:164-167.
19. Lee WM, Kamruzzaman SM, Song YB, Cho JY, Park HJ, Rhee MH. Inhibitory activities of red ginseng acidic polysaccharide in platelet aggregation. J Ginseng Res 2008;2:7-78.
20. Park JM, Rhee MH, Shin HJ, Song YB, Hyun HC, Park KH, Cho HJ, Choi SA, Kang HC, Kim KJ et al. Inhibitory effects of Panaxatriol from Panax ginseng C.A. Meyer on phosphoinositide breakdown induced by thrombin in platelets. J Ginseng Res 2008;2:107-11.
21. Park KM, Rhee MH, Park HJ. Panaxadiol and panaxatriol from Panax ginseng C.A. Meyer inhibit the synthesis of thromboxane A2 in adrenaline-stimulated human platelet aggregation. Korean J Ginseng Sci 1994;18:44-48.
22. Park HJ, Rhee MH, Park KM, Nam KY, Park KH. Panaxadiol from Panax ginseng C.A. Meyer inhibits synthesis of thromboxane A2 in platelet aggregation induced by thrombin. Korean J Ginseng Sci 199;17:11-14.
23. Kimura Y, Okuda H, Arichi S. Effects of various ginseng saponins on 5-hydroxytryptamine release and aggregation in human platelets. J Pharm Pharmacol 1988;40:88-84.
24. Lee WM, Kim SD, Park MH, Cho JY, Park HJ, Seo GS, Rhee MH. Inhibitory mechanisms of dihydroginsenoside Rg in platelet aggregation: critical roles of ERK2 and cAMP. J Pharm Pharmacol 2008;60:151-156.
25. Reuter H, Niemeyer G, Gross R. Studies of the aggregation of human blood platelets. On the inhibition of platelet aggregation in EDTA plasma following incubation at 7 degrees C. Klin Wochenschr 1967;45:1147-1149.
26. Lagarde M, Menashi S, Crawford N. Localisation of phospholipase A2 and diglyceride lipase activities in human platelet intracellular membranes. FEBS Lett 1981;124:2-26.
27. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002;8:1227-124.
28. FitzGerald GA. Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. Am J Cardiol 1991;68:11B-15B.
29. Clutton P, Folts JD, Freedman JE. Pharmacological control of platelet function. Pharmacol Res 2001;44:255-264.
30. Halushka PV, Allan CJ, Davis-Bruno KL. Thromboxane A2 receptors. J Lipid Mediat Cell Signal 1995;12:61-78.
31. Teng CM, Kuo SC, Ko FN, Lee JC, Lee LG, Chen SC, Huang TF. Antiplatelet actions of panaxynol and ginsenosides isolated from ginseng. Biochim Biophys Acta 1989;990:15-20.
32. Samuelsson B. Biosynthesis and metabolism of prostaglandins. Prog Biochem Pharmacol 1967;:59-70.
33. Sun FF, Chapman JP, McGuire JC. Metabolism of prostaglandin endoperoxide in animal tissues. Prostaglandins 1977;14:1055-1074.
34. Savage B, Cattaneo M, Ruggeri ZM. Mechanisms of platelet aggregation. Curr Opin Hematol 2001;8:270-276.
35. Lee SR, Park JH, Choi KJ, Kim ND. Inhibitory effects of ginsenoside Rg on platelet aggregation and its mechanism of action. Korean J Ginseng Sci 1997;21:12-140.
36. Pace-Asciak CR, Reynaud D, Demin P, Aslam R, Sun A. A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition. J Pharmacol Exp Ther 2002;01:618-624.
37. Moers A, Wettschureck N, Offermanns S. G1-mediated signaling as a potential target for antiplatelet drugs. Drug News Perspect 2004;17:49-498.
38. Cho HJ, Choi SA, Kim CG, Hong JH, Park HJ, Park HJ. Dietary spinach saponin-enriched lipophilic fraction inhibits platelet aggregation and blood coagulation. J Med Food 2011;14:784-791.